Urist Marshall bought RPRX

November 5, 2025 · Form 4 insider transaction

Urist Marshall bought 4,626 shares of Royalty Pharma plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
4,626
Price
$0.00
Total value
N/A
Role—
SecurityClass A Ordinary Shares
Transaction codeA: Grant or award
Transaction dateNovember 5, 2025
Filing dateNovember 7, 2025
Shares owned after43,882
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

View the original Form 4 on SEC EDGAR